相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NAFLD and diabetes mellitus
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis
A. L. L. Rocha et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies
Irene Petersen et al.
CLINICAL EPIDEMIOLOGY (2017)
Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease
J. J. Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife
Monika Sarkar et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies
Mohammad Ehsanul Karim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?
Christopher D. Byrne et al.
DIABETOLOGIA (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
Gurkan Bozdag et al.
HUMAN REPRODUCTION (2016)
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies
A. Katrina Loomis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies
L. Li et al.
OBESITY REVIEWS (2016)
Backdating of events in electronic primary health care data: should one censor at the date of last data collection
Cormac J. Sammon et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study
Tao Ding et al.
BMJ OPEN (2016)
5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
Maryam Nasiri et al.
ENDOCRINOLOGY (2015)
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
Dorte Glintborg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease
E. Vassilatou et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity
Kavya Anjani et al.
JOURNAL OF HEPATOLOGY (2015)
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
Eric I. Benchimol et al.
PLOS MEDICINE (2015)
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity
Samantha Cassar et al.
CLINICAL ENDOCRINOLOGY (2015)
Are Women With Polycystic Ovarian Syndrome at a High Risk of Non-Alcoholic Fatty Liver Disease; A Meta-Analysis
Mandi Ramezani-Binabaj et al.
HEPATITIS MONTHLY (2014)
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
Matthew J. Armstrong et al.
HEPATOLOGY (2014)
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
Michael W. O'Reilly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Sociodemographic Trends in the Incidence of Pancreatic and Biliary Tract Cancer in UK Primary Care
Margaret G. Keane et al.
PLOS ONE (2014)
Non-alcoholic fatty liver disease in common endocrine disorders
Jonathan M. Hazlehurst et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
OBESITY REVIEWS (2013)
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Harpal S. Randeva et al.
ENDOCRINE REVIEWS (2012)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Bart C. J. M. Fauser et al.
FERTILITY AND STERILITY (2012)
Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance
Helen Jones et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Genetic Syndromes of Severe Insulin Resistance
Robert K. Semple et al.
ENDOCRINE REVIEWS (2011)
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
E. Vassilatou et al.
HUMAN REPRODUCTION (2010)
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Robert A. Wild et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome
Mei-Jou Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Interactions of sex hormone-binding globulin with target cells
William Rosner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Pathogenesis of non-alcoholic fatty liver disease
J. K. Dowman et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Creating medical and drug code lists to identify cases in primary care databases
Shreya Dave et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Oligoanovulation with polycystic ovaries but not overt hyperandrogenism
Didier Dewailly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
分享论文
